Home/Database/IFN-lambda-1
Immune SupportClinical

IFN-lambda-1

Recombinant human interferon lambda-1 (interleukin-29)

N/A Amino Acids · MW: ~19,000 Da

Amino Acids

N/A

Molecular Weight

~19,000 Da

Half-life

3-6 hours

Research Score

4.2

Studies

220

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is IFN-lambda-1?

A type III interferon that drives antiviral responses in epithelial tissues through the IFNLR receptor system. It is of special interest for mucosal viral defense because it can produce strong local antiviral activity with more restricted systemic signaling than type I interferons.

Key Benefits & Mechanisms

mucosal antiviral defense

epithelial barrier support

interferon-stimulated gene activation

potentially lower systemic inflammatory burden

Research Summary

Human interferon lambda-1 has been studied for antiviral activity at barrier tissues such as the respiratory and gastrointestinal mucosa. Its selective receptor distribution makes it a high-interest candidate for antiviral immune support research.